PTPRC and infection: The percentage of EBER+ cells among CD45+ cells was decreased at day 24 post-infection in a dose-dependent manner (10% with 45 μg/ml of ACV, 19% with 15 μg/ml, 24% with 5 μg/ml, and 32% without ACV, n = 1) (Fig. 6C).